New Delhi, February 21: Pune-based Serum Institute of India CEO Adar Poonawalla requested the countries to ‘be patient’ as they await the Covishield supplies, adding that SII is trying to maintain a balance between the needs of India and the world.
“Dear countries and governments, as you await COVISHIELD supplies, I humbly request you to please be patient, Serum Institute of India has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best,” Poonawalla said.
SII has been asked to prioritise India’s vaccine needs and balance it out with the supplies to the rest of the world who are procuring the AstraZeneca vaccine doses from India.
Earlier, he said that SII makes 70 to 80 million doses every month and the planning is underway for distribution to India and foreign countries.
Poonawalla said many countries have been writing to India and the Prime Minister’s Office (PMO) for vaccines to be supplied from Serum Institute to their countries and they are trying to make everyone happy.